Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 08-2019 | 05-2019 | 02-2019 | 11-2018 | 08-2018 | |
| Operating Expenses | 0 | 941 | 758 | 557 | 0 |
| Operating Income | N/A | -941 | -758 | -557 | N/A |
| Other Income | 0 | 596 | 333 | 0 | 0 |
| Pre-tax Income | 0 | -345 | -425 | -557 | 0 |
| Net Income Continuous | N/A | -345 | -425 | -557 | N/A |
| Net Income | $N/A | $-345 | $-425 | $-557 | $N/A |
| EPS Basic Total Ops | N/A | -45.87 | -59.36 | -86.35 | N/A |
| EPS Basic Continuous Ops | N/A | -45.20 | -59.77 | -85.65 | N/A |
| EPS Diluted Total Ops | N/A | -45.87 | -107.94 | -86.35 | N/A |
| EPS Diluted Continuous Ops | N/A | -45.20 | -59.77 | -85.65 | N/A |
| EBITDA(a) | $N/A | $-941 | $-758 | $-557 | $N/A |